NL6605903A - - Google Patents

Info

Publication number
NL6605903A
NL6605903A NL6605903A NL6605903A NL6605903A NL 6605903 A NL6605903 A NL 6605903A NL 6605903 A NL6605903 A NL 6605903A NL 6605903 A NL6605903 A NL 6605903A NL 6605903 A NL6605903 A NL 6605903A
Authority
NL
Netherlands
Application number
NL6605903A
Other versions
NL154744B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6605903A publication Critical patent/NL6605903A/xx
Publication of NL154744B publication Critical patent/NL154744B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
NL666605903A 1965-05-05 1966-05-02 Werkwijze ter bereiding van gestageen werkzame 17beta-mono-esters en 3-enol17beta-diesters van 17alfa-ethinyl-18-methyl-19-nor-testosteron, alsmede werkwijze ter bereiding van een farmaceutisch preparaat en gevormd farmaceutisch preparaat. NL154744B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DESC037001 1965-05-05

Publications (2)

Publication Number Publication Date
NL6605903A true NL6605903A (de) 1966-11-07
NL154744B NL154744B (nl) 1977-10-17

Family

ID=7434083

Family Applications (1)

Application Number Title Priority Date Filing Date
NL666605903A NL154744B (nl) 1965-05-05 1966-05-02 Werkwijze ter bereiding van gestageen werkzame 17beta-mono-esters en 3-enol17beta-diesters van 17alfa-ethinyl-18-methyl-19-nor-testosteron, alsmede werkwijze ter bereiding van een farmaceutisch preparaat en gevormd farmaceutisch preparaat.

Country Status (6)

Country Link
US (1) US3514514A (de)
BE (1) BE680569A (de)
CH (1) CH467762A (de)
FR (1) FR6842M (de)
GB (1) GB1069779A (de)
NL (1) NL154744B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2036380A1 (de) * 1970-07-18 1972-01-27 Schering AG Berlin und Bergkamen 1000 Berlin 18 Methyl 17 alpha athmyl testosteron ester
US4181721A (en) * 1975-10-27 1980-01-01 Schering Aktiengesellschaft Depot preparations in an oily, unsaturated solution for intramuscular injection
US5010070A (en) * 1987-06-15 1991-04-23 Warner-Lambert Company Graduated estrogen contraceptive
EP3697421B1 (de) * 2017-10-19 2024-04-17 Evestra, Inc. Länger wirkende progestin-prodrug-kontrazeptiva

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2601287A (en) * 1949-08-18 1952-06-24 Upjohn Co Partial synthesis of progesterone
US2798879A (en) * 1953-04-15 1957-07-09 Upjohn Co 19-nortestosterone acylates and 3-enol acylates thereof
US2868809A (en) * 1954-08-12 1959-01-13 Upjohn Co 19-nortestosterone phenyl alkanoates
US3006933A (en) * 1958-07-09 1961-10-31 American Cyanamid Co 11alpha-hydrocarbylsulfonyloxy-3,5-pregnadienes
US3231589A (en) * 1963-07-25 1966-01-25 American Home Prod 13beta-alkyl-4-gonen-3-ones

Also Published As

Publication number Publication date
US3514514A (en) 1970-05-26
CH467762A (de) 1969-01-31
NL154744B (nl) 1977-10-17
GB1069779A (en) 1967-05-24
FR6842M (de) 1969-04-08
BE680569A (de) 1966-11-07

Similar Documents

Publication Publication Date Title
FR5612M (de)
FR6842M (de)
JPS4121728Y1 (de)
JPS436950Y1 (de)
JPS4412611Y1 (de)
JPS4429116Y1 (de)
JPS443238Y1 (de)
JPS4527905Y1 (de)
JPS465489Y1 (de)
NL6606678A (de)
BE674362A (de)
BE674708A (de)
SE336266B (de)
BE674514A (de)
BE674508A (de)
BE665235A (de)
BE674524A (de)
BE674477A (de)
BE666658A (de)
BE674400A (de)
BE674747A (de)
BE674767A (de)
BE674839A (de)
BE674974A (de)
BE666799A (de)

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: SCHERING